These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7378926)

  • 21. GLC determination of gamma-hydroxyphenylbutazone in plasma.
    Midha KK; McGilveray IJ; Charette C
    J Pharm Sci; 1974 Nov; 63(11):1751-4. PubMed ID: 4427237
    [No Abstract]   [Full Text] [Related]  

  • 22. Determination of phenylbutazone and oxyphenbutazone in plasma and urine samples of horses by high-performance liquid chromatography and gas chromatography-mass spectrometry.
    Neto LM; Andraus MH; Salvadori MC
    J Chromatogr B Biomed Appl; 1996 Apr; 678(2):211-8. PubMed ID: 8738024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The disposition of suxibuzone in the horse.
    Delbeke FT; Vynckier L; Debackere M
    J Vet Pharmacol Ther; 1993 Sep; 16(3):283-90. PubMed ID: 8230399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic and pharmacodynamic studies on phenylbutazone and oxyphenbutazone in goats.
    Cheng Z; Welsh E; Nolan A; McKellar QA
    Vet Rec; 1997 Jan; 140(2):40-3. PubMed ID: 9123796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxyphenbutazone and phenylbutazone determination in plasma and urine by GLC.
    Bruce RB; Maynard WR; Dunning LK
    J Pharm Sci; 1974 Mar; 63(3):446-8. PubMed ID: 4820382
    [No Abstract]   [Full Text] [Related]  

  • 26. Mechanisms of inhibition of tolbutamide metabolism: phenylbutazone, oxyphenbutazone, sulfaphenazole.
    Pond SM; Birkett DJ; Wade DN
    Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 1):573-9. PubMed ID: 913025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of phenylbutazone and its metabolites in the horse.
    Gerring EL; Lees P; Taylor JB
    Equine Vet J; 1981 Jul; 13(3):152-7. PubMed ID: 7297544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparison of bumadizone-, phenylbutazone- and oxyphenbutazone-plasma levels after a single oral dose of phenylbutazone and of bumadizone, respectively (author's transl)].
    Spahn H; Mutschler E; Geissler HE; Faust-Tinnefeldt G
    Arzneimittelforschung; 1981; 31(3):499-503. PubMed ID: 6894380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitory effects of intravenous chloramphenicol sodium succinate on the disposition of phenylbutazone in horses.
    Gerken DF; Sams RA
    J Pharmacokinet Biopharm; 1985 Oct; 13(5):467-76. PubMed ID: 3834064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of phenylbutazone and its metabolite oxyphenbutazone in miniature donkeys.
    Matthews NS; Peck KE; Taylor TS; Mealey KL
    Am J Vet Res; 2001 May; 62(5):673-5. PubMed ID: 11341383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Studies on the combination of drugs. IV. Effect of 4-hydroxyantipyrine and N-acetyl-p-aminophenol on the metabolism of phenylbutazone, oxyphenbutazone and ketophenylbutazone].
    Niwa H; Nakayama T
    Yakugaku Zasshi; 1968 Jul; 88(7):838-42. PubMed ID: 5750523
    [No Abstract]   [Full Text] [Related]  

  • 32. Disposition and urinary excretion of phenylbutazone in normal and febrile greyhounds.
    Mills PC; Ng JC; Hrdlicka J; Auer DE
    Res Vet Sci; 1995 Nov; 59(3):261-6. PubMed ID: 8588103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simultaneous determination of phenylbutazone and oxyphenbutazone in plasma by high-speed liquid chromatography.
    Pound NJ; Sears RW
    J Pharm Sci; 1975 Feb; 64(2):284-7. PubMed ID: 1127584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acetanilide oxidation in phenylbutazone-associated hypoplastic anaemia.
    Cunningham JL; Leyland MJ; Delamore IW; Evans DA
    Br Med J; 1974 Aug; 3(5926):313-7. PubMed ID: 4411815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical pharmacokinetics of phenylbutazone.
    Aarbakke J
    Clin Pharmacokinet; 1978; 3(5):369-80. PubMed ID: 359213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma and serum concentrations of phenylbutazone and oxyphenbutazone in racing Thoroughbreds 24 hours after treatment with various dosage regimens.
    Soma LR; Sams R; Duer W; Tobin T; Woodward C; McDonald J
    Am J Vet Res; 1985 Apr; 46(4):932-8. PubMed ID: 4014842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of desipramine on intestinal absorption of phenylbutazone and other drugs.
    Consolo S; Garattini S
    Eur J Pharmacol; 1969; 6(3):322-6. PubMed ID: 5799193
    [No Abstract]   [Full Text] [Related]  

  • 38. Phenylbutazone kinetics and metabolite concentrations in the horse after five days of administration.
    Soma LR; Gallis DE; Davis WL; Cochran TA; Woodward CB
    Am J Vet Res; 1983 Nov; 44(11):2104-9. PubMed ID: 6650958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Determination of bumadizone, phenylbutazone and oxyphenbutazone in human plasma by high-performance liquid chromatography (author's transl)].
    Spahn H; Mutschler E
    Arzneimittelforschung; 1981; 31(3):495-9. PubMed ID: 6894379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of oral cimetidine on plasma concentrations of phenylbutazone in horses.
    Christensen JM; Blythe LL; Craig AM
    J Vet Pharmacol Ther; 1985 Dec; 8(4):404-12. PubMed ID: 4094031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.